The measurement of mood

Sjöberg, Lennart; Svensson, Erland; Persson, Lars‐Olof

doi:10.1111/j.1467-9450.1979.tb00677.x

Cited by 270 publications

(114 citation statements)

References 36 publications

Supporting

Mentioning

108

Contrasting

Unclassified

Order By: Relevance

“…No significant changes between groups were observed for Overall Mood [25] and the HADS Anxiety score (Ps>0.05). The bariatric surgery patients' primary HRQoL scores were also compared to population norms from individuals with a BMI<30, adjusted for age and gender, to reflect the same distribution as the study sample.…”

Section: Karlsson Et Al 2007mentioning

confidence: 96%

Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies

Andersen

Aasprang²,

Karlsen

et al. 2015

Surgery for Obesity and Related Diseases

136

103

View full text Add to dashboard Cite

Impaired health-related quality of life (HRQoL) is common in bariatric surgery candidates and is often one of the motivating factors for seeking bariatric surgery. Although many studies have reported changes in HRQoL after bariatric surgery, few are long-term prospective studies and no systematic review has been conducted. A systematic database search identified studies reporting HRQoL preoperatively and ≥ 5 years after bariatric surgery. Change in HRQoL over time was the outcome variable, divided into primary and secondary outcomes. Seven prospective cohort studies met the inclusion criteria. Eight HRQoL measures and six surgical methods were identified. Longterm follow-up time ranged from 5-10 years, sample sizes from 44 to 655 patients, and follow-up rates from 61 to 92%. None of the seven studies were randomized controlled trails and only two studies used control groups. Six out of seven studies showed statistically significant improvements in all of the primary outcomes, while one study showed statistically significant improvements in one of two primary outcomes. Of the statistically significant HRQoL improvements, 92 percent were clinically meaningful. Peak improvements in primary HRQoL outcomes were typically observed during the first years of follow-up, followed by a gradual decline that seemed to stabilize five years postoperatively. Long-term HRQoL scores typically remained improved relative to preoperative scores but were somewhat below population norm scores. In conclusion, while bariatric surgery candidates reported impaired HRQoL pre-surgically, their HRQoL improved considerably after bariatric surgery and much of the initial HRQoL improvements were maintained over the long term.

show abstract

Section: Karlsson Et Al 2007mentioning

confidence: 96%

Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies

Andersen

Aasprang²,

Karlsen

et al. 2015

Surgery for Obesity and Related Diseases

136

103

View full text Add to dashboard Cite

show abstract

“…MACL contains 38 adjectives on a four-point response scale with two acceptance and two rejection categories. 18 It measures three major bipolar dimensions of mood: pleasantness/unpleasantness (e.g., satisfied, optimistic/depressed, resigned), activation/ deactivation (e.g., alert, active/passive, apathetic) and calmness/tension (e.g., relaxed/tense, distressed). The three mood dimensions are highly correlated and an overall mood score is calculated to describe general mood.…”

Section: Weight Parametersmentioning

confidence: 99%

Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study

et al. 2007

View full text Add to dashboard Cite

Objective: To examine trends and effects of weight loss treatment on health-related quality of life (HRQL) in the severely obese over 10 years. Design: Swedish obese subjects (SOS) intervention study is a controlled, longitudinal trial of the health effects of weight loss in the severely obese. Subjects: A total of 655 of 851 surgically treated and 621 of 852 conventionally treated obese men (body mass index, BMIX34) and women (BMIX38) who completed 10 years of the study. Measurements: HRQL was assessed before treatment and after 0.5, 1, 2, 3, 4, 6, 8 and 10 years. Results: HRQL change during the 10-year observation period largely followed phases of weight loss, weight regain and weight stability. Improvements and deteriorations in HRQL were associated with the magnitude of weight loss or regain, except regarding anxiety. Peak improvements in the surgical group were observed during the first year of weight loss, whereas the weight regain phase (mainly between 1-and 6-year follow-up) was accompanied by a gradual decline in HRQL. The period from 6-to 10-year follow-up was characterized by relatively stable observations in both weight and HRQL. At 10 years, net gains were noted in all HRQL domains compared to baseline. Comparisons of treatment effects on HRQL in the surgical vs conventional group after 10 years showed significantly better outcome in the surgical group on current health perceptions, social interaction, psychosocial functioning and depression, whereas no significant differences were found for overall mood and anxiety. Long-term results of the study suggest that a maintained weight loss of about 10% is sufficient for positive long-term effects on HRQL, a limit that was reached in about two-thirds of the surgically treated patients who completed 10 years of the study. Conclusion: Long-lasting weight reduction in the severely obese has a general long-standing positive outcome on HRQL. Bariatric surgery is a favorable option for the treatment of severe obesity, resulting in long-term weight loss and HRQL improvements in a majority of patients. However, difficulties among some surgical patients to control and maintain weight loss over time should not be ignored. Future research should study if the long-term efficacy of bariatric surgery may be further enhanced by implementing lifestyle modification techniques in the postoperative management of patients.

show abstract

“…Mental well-being was measured by the Mood Adjective Check List (MACL) (Sjöberg et al, 1979). It contains 71 adjectives which are aggregated into 6 bipolar dimensions: pleasantness/unpleasantness, activation/deactivation, calmness/tension, extraversion/introversion, positive/negative social orientation and control/lack of control.…”

Section: Indicator and Standard Measuresmentioning

confidence: 99%

Clinical relevance of single item quality of life indicators in cancer clinical trials

Bernhard

Sullivan

Hürny³

et al. 2001

Br J Cancer

View full text Add to dashboard Cite

SummaryWe investigated the hypothesis that global single-item quality-of-life indicators are less precise for specific treatment effects (discriminant validity) than multi-item scales but similarly efficient for overall treatment comparisons and changes over time (responsiveness) because they reflect the summation of the individual meaning and importance of various factors. Linear analogue self-assessment (LASA) indicators for physical well-being, mood and coping were compared with the Hospital Anxiety and Depression Scale (HAD), the Mood Adjective Check List (MACL) and the emotional behaviour and social interaction scales of the Sickness Impact Profile (SIP) in 84 patients with early breast cancer receiving adjuvant therapy. Discriminant validity was investigated by multitrait-multimethod correlation, responsiveness by standardized response mean (SRM). Discriminant validity of the indicators was present at baseline but less under treatment. Responsiveness was demonstrated by the expected pattern among treatments (P = 0.008). In patients without chemotherapy, the SRMs indicated moderate (0.5-0.8) to large (>0.8) improvements in physical well-being (0.70), coping (0.92), HAD anxiety (0.89) and depression (1.19), and MACL mental well-being (0.68). In patients with chemotherapy for the first 3 months, small but clinically significant improvements (>).2) included mood (0.38), coping (0.41), HAD axiety (0.31) and MACL mental well-being (0.35). Patients with 6 months chemotherapy showed no changes. The indicators also reflected mood disorders (HAD) and marked psychosocial dysfunction (SIP) at baseline and under treatment according to pre-defined cut-off levels. Global indicators were confirmed to be efficient for evaluating treatments overall and changes over time. The lower reliability of single as opposed to multi-item scales affects primarily their discriminant validity. This is less decisive in large sample sizes. PATIENTS AND METHODS SampleThis study included a consecutive sample of patients with operable breast cancer from Sahlgrenska University Hospital in Göteborg which were randomized into one of the following IBCSG adjuvant therapy trials: Trial VI, for pre-and peri-menopausal, nodepositive (N+) patients; Trial VII, for postmenopausal N+ patients; Trial VIII, for pre-and peri-menopausal, node-negative (N-) patients; Trial IX, for postmenopausal N-patients. In these trials, varying schedules of chemotherapy, endocrine therapy and their combinations were studied. The chemotherapy consisted of CMF (cyclophosphamide, methotrexate and 5-fluorouricil); the endocrine therapy was Tamoxifen or LH-RH (luteinizing hormone-releasing hormone) analogue. In patients with conservative surgery (quadrantectomy or lumpectomy) radiotherapy was started 2 weeks after the last chemotherapy course, or within 3 months in case of endocrine therapy alone. The randomization in Trials VI and VII was stratified by institution, type of surgery and oestrogen receptor (ER) status. The randomization in Trials VIII and IX was stratified by i...

show abstract

The measurement of mood

Cited by 270 publications

References 36 publications

Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies

Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies

Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study

Clinical relevance of single item quality of life indicators in cancer clinical trials

Contact Info

Product

Resources

About